Intocell
Intocell is a biotechnology company that develops antibody drug conjugate (ADC) platform technologies.
Operating in biotechnology, information technology, medical based in Asia-Pacific (APAC), Intocell was founded in 2015.
The company sits in the biotechnology, information technology, medical segment, where it competes on its core product or service.
The company is recorded as being based in Asia-Pacific (APAC).
The company is listed at the Series_C stage of development.
Recorded headcount: c_00001_00010 employees.
Total disclosed funding stands at about $35B.
| Sector | Biotechnology, Information Technology, Medical |
|---|---|
| Headquarters | Asia-Pacific (APAC) |
| Founded | 2015 |
| Employees | c_00001_00010 |
| Stage | series_c |
| Total funding | $35,000,000,000 |
Website: www.intocell.co.kr
Browse related
Contact details and direct channels are available to signed-in members.
Create a free account
Create a free account